Clinical Trial Update: A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ziltivekimab versus placebo in participants with heart failure and systemic inflammation; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Heart Failure, Systemic Inflammation | Phase 3 | Status: RECRUITING